Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma

Jing Tang; Yue Li; Jiazhu Wu; Haorui Shen; Hua Yin; Jinhua Liang; Li Wang; Jianyong Li; Yi Xia; Wei Xu

doi:10.1016/j.gendis.2023.04.012

您当前的位置：

首页 >

文章列表页 >

Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma

Short communication | 更新时间：2024-02-04

- Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
- Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
- Genes & Diseases 2024年11卷第2期
- 作者机构：
  
  1. Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital,Jiangsu,Nanjing,China,210029
  2. Collaborative Innovation Center for Cancer Personalized Medicine,Jiangsu,Nanjing,China,210029
  3. Key Laboratory of Hematology of Nanjing Medical University,Jiangsu,Nanjing,China,210029
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.04.012
  中图分类号：
- 纸质出版日期：2024，
  
  网络出版日期：2024-3-1，
扫描看全文
Jing Tang, Yue Li, Jiazhu Wu, 等. Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma[J]. Genes & Diseases, 2024,11(2).

Jing Tang, Yue Li, Jiazhu Wu, et al. Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma[J]. Genes & Diseases, 2024,11(2).
Jing Tang, Yue Li, Jiazhu Wu, 等. Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma[J]. Genes & Diseases, 2024,11(2). DOI： 10.1016/j.gendis.2023.04.012.

Jing Tang, Yue Li, Jiazhu Wu, et al. Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma[J]. Genes & Diseases, 2024,11(2). DOI： 10.1016/j.gendis.2023.04.012.

摘要

Abstract

关键词

Keywords

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据

Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma

Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma

DOI：10.1016/j.gendis.2023.04.012

摘要

Abstract

关键词

Keywords

references